Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like BMS to Buy Oncology-Focused Turning Point for $4.1B, Netting Three Breakthrough Therapy Candidates June 5, 2022 Study Suggests Covis Pharma’s Preterm Birth Drug Carries Cancer Risk November 9, 2021 J&J Finalizes Executive Committee Ahead of Splitting Pharma, Consumer Operations December 12, 2021
BMS to Buy Oncology-Focused Turning Point for $4.1B, Netting Three Breakthrough Therapy Candidates June 5, 2022